✦ LIBER ✦

Triplet Combination of Fluoropyrimidines, Oxaliplatin, and Irinotecan in the First-Line Treatment of Metastatic Colorectal Cancer

✍ Scribed by Gianluca Masi; Enrico Vasile; Fotios Loupakis; Simona Bursi; Sergio Ricci; Iacopo Petrini; Andrea Fontana; Giacomo Allegrini; Alfredo Falcone

Book ID: 119935123
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 120 KB
Volume: 7
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2008.n.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN70 MODELLING THE COST EFFECTIVENESS O

PCN70 MODELLING THE COST EFFECTIVENESS OF FIRST-LINE COMBINATION TREATMENT WITH BEVACIZUMAB PLUS IRINOTECAN AND INFUSIONAL FLUOROPYRIMIDINES VERSUS IRINOTECAN AND INFUSIONAL FLUOROPYRIMIDINES IN METASTATIC COLORECTAL CANCER PATIENTS IN SWEDEN

✍ C Holmberg; R Aultman; U Siebert; E Sabate; M Gyldmark 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Phase II trial of gemcitabine plus UFT a

Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer

✍ Lee, Keun-Wook; Kim, Yu Jung; Lee, Kyung-Hun; Han, Sae-Won; Kim, Tae-Yong; Oh, D 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 257 KB

Oxaliplatin plus irinotecan promising as

Oxaliplatin plus irinotecan promising as first-line treatment for advanced colorectal cancer

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Irinotecan plus fluorouracil: first-line

Irinotecan plus fluorouracil: first-line in metastatic colorectal cancer

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

Updated efficacy and toxicity analysis o

Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : Intergroup trial N9741 in first-line treatment of metastatic colorectal cancer

✍ Amanda C. Ashley; Daniel J. Sargent; Steven R. Alberts; Axel Grothey; Megan E. C 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

## Abstract ## BACKGROUND. Efficacy and toxicity of oxaliplatin (Eloxatin; Sanofi‐Aventis, Paris, France) combined with irinotecan (IROX) were examined in 383 patients enrolled on the IROX arm of Intergroup Study N9741. ## METHODS. This IROX regimen was oxaliplatin 85 mg/m^2^ and irinotecan 200

The combination of capecitabine and irin

The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer

✍ Sang Joon Shin; Joong Bae Ahn; Hye Jin Choi; Byoung Chul Cho; Hei-Cheul Jeung; S 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 311 KB